A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer
出版年份 2011 全文链接
标题
A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 23, Issue 6, Pages 1441-1448
出版商
Oxford University Press (OUP)
发表日期
2011-10-12
DOI
10.1093/annonc/mdr444
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer
- (2010) Chris Twelves et al. Clinical Breast Cancer
- Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
- (2010) Javier Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells
- (2010) Jan-Shiang Taur et al. XENOBIOTICA
- Eribulin Binds at Microtubule Ends to a Single Site on Tubulin To Suppress Dynamic Instability
- (2009) Jennifer A. Smith et al. BIOCHEMISTRY
- Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety and biomarker results from Japanese patients phase II studies
- (2009) M Toi et al. BRITISH JOURNAL OF CANCER
- A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies
- (2009) S. Goel et al. CLINICAL CANCER RESEARCH
- Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors
- (2009) A. R. Tan et al. CLINICAL CANCER RESEARCH
- Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy
- (2009) P. H. O'Donnell et al. CLINICAL CANCER RESEARCH
- Phase II Study of Gemcitabine Monotherapy as a Salvage Treatment for Japanese Metastatic Breast Cancer Patients after Anthracycline and Taxane Treatment
- (2009) Y. Suzuki et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2009) Linda T. Vahdat et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
- (2009) Alvaro Moreno-Aspitia et al. MAYO CLINIC PROCEEDINGS
- MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome
- (2009) M Cizmarikova et al. PHARMACOGENOMICS JOURNAL
- Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes
- (2008) Takanori Ishida et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase
- (2008) T. Okouneva et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now